Correlation between reduced p21WAF1/CIP1 expression and abnormal p53 expression in esophageal carcinomas

International Journal of Oncology

Volumn 11, Issue 4, 1997, Pages 703-708

  Toh, Yasushi ^a,b,c   Kuwano, Hiroyuki ^a   Sonoda, Kohzo ^a   Saeki, Hiroshi ^a   Kawaguchi, Hidetoshi ^a   Kitamura, Kaoru ^a   Nakashima, Hideaki ^a   Sugimachi, Keizo ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Cell cycle; Esophagus; Immunohistochemistry; p21WAF1 CIP1; p53; Squamous cell carcinoma

Indexed keywords

PROTEIN P21;

ADULT; AGED; ARTICLE; CARCINOGENESIS; DNA DAMAGE; DNA REPLICATION; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; SQUAMOUS CELL CARCINOMA;

EID: 0030931714     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.4.703     Document Type: Article

References (29)

1. Casson AG (Ed): Esophageal cancer. In: Oncogene activation in esophageal cancer. R.G. Landes Company, Austin, pp3-24, 1992.
2. Lu SH, Hsieh LL, Luo FC and Weinstein IB: Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int J Cancer 42: 502-505, 1988.
3. Hollstein MC, Metcalf RA, Welsh JA, Montesano R and Harris CC: Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 87: 9958-9961, 1990.
4. Hollstein M, Peri L, Mandard A, Welsh J, Montesano R, Metcalf R, Bak M and Harris C: Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of raj mutations. Cancer Res 51: 4102-4106, 1991.
5. Bennett WP, Hollstein MC, He A, Zhu SM, Resau JH, Trump BF, Metcalf RA, Welsh JA, Midgley C, Lane DP and Harris CC: Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene 6: 1779-1784, 1991.
6. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY and Yang CS: p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 54: 4342-4346, 1994.
7. Wang LD, Hong JY, Qiu SL, Gao H and Yang CS: Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 53: 1783-1787, 1993.
8. Nakagawa H, Zukerberg L, Togawa K, Meltzer SJ, Nishihara T and Rustgi AK: Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer 76: 541-549, 1995.
9. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH and Weinstein IB: Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52: 2980-2983, 1992.
10. Sherr CJ and Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Gene Dev 9: 1149-1163, 1995.
11. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
12. Harper JW, Adami OR, Wei N, Keyomarsi K and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
13. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994.
14. Li R, Waga S, Hannon GJ, Beach D and Stillman B: Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537, 1994.
15. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Cannon JV and Lane DP: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7559, 1990.
16. Levine AJ, Momand J and Finlay CA: The p53 tumour suppressor gene. Nature 351: 453-456, 1991.
17. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919, 1995.
18. Ciechanover A, Di Giuseppe JA, Bercovich B, Orian A, Richter JD, Schwartz AL and Brodeur GM: Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci USA 88: 139-143, 1991.
19. Scheffner M, Huibregtse JM, Vierstra RD and Howley PM: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505, 1993.
20. Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Bertacca G, Chella A, Merlo G, Angeletti CA, Palma PD and Bevilacqua G: p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene 12: 1319-1324, 1996.
21. Zeng YX and El-Deiry WS: Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 12: 1557-1564, 1996.
22. Di Giuseppe JA, Redston MS, Yeo CJ, Kern SE and Hruban RH: p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am J Pathol 147: 884-888, 1995.
23. Michieli P, Chelid M, Lin D, Pierce JH, Mercer WE and Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395, 1994.
24. Steinman RA, Hoffman B, Iro A, Guillouf C, Lieberman DA and El-Houseini ME: Induction of p21 (WAF1/CIP1) during differentiation. Oncogene 9: 3389-3396, 1994.
25. Johnson M, Dimitrov D, Vojta PJ, Barrett JC, Noda A, Pereira-Smith OM and Smith JR: Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol Carcinogen 11: 59-64, 1994.
26. Barboule N, Mazars P, Baldin V, Vidal S, Jozan S, Martel P and Valette A: Expression of p21WAF1/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma. Int J Cancer 63: 611-615, 1995.
27. Elbendary AA, Cirisano FD, Evans AC, Davis PL, Iglehart JD, Marks JR and Berchuck A: Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res 2: 1571-1575, 1996.
28. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T and Kinzler K: p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Gene Develop 9: 935-944, 1995.
29. Schwaller J, Koeffler HP, Niklaus G, Loetscher P, Nagel S, Fey MF and Tobler A: Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest 95: 973-979, 1995.